Latest / The BioHub - by Avetix
Episode 198 - Andrew Obenshain - CEO Inventiva
In this episode of The BioHub Podcast, Max sits down with Andrew Obenshain, CEO of Inventiva.
Andrew brings more than 20 years of experience across global drug development, regulatory strategy, and commercialization. Before joining Inventiva, he led bluebird bio through its transformation into a global commercial-stage gene therapy company and previously held senior leadership roles at Shire and Genzyme.
Inventiva is a late-stage clinical biopharmaceutical company developing oral therapies for patients with significant unmet medical needs, with its lead program focused on MASH (metabolic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.